| Literature DB >> 27059905 |
Shamik Dholakia1, Youssof Oskrochi2, Graham Easton2, Vassilios Papalois3.
Abstract
The potential to reverse diabetes has to be balanced against the morbidity of long-term immunosuppression associated with transplantation. For a patient with renal failure, the treatment of choice is often a simultaneous transplant of the pancreas and kidney or pancreas after kidney. For a patient with glycaemic instability, choices between a solid organ or islet transplant have to be weighed against benefits and risks of remaining on insulin. Results of simultaneous transplant of the pancreas and kidney transplantation are comparable to other solid-organ transplants, and there is evidence of improved quality of life and life expectancy. There is some evidence of benefit with respect to the progression of secondary diabetic complications in patients with functioning transplants for several years. © The Royal Society of Medicine.Entities:
Keywords: Chronic diseases; endocrinology; evidence-based practice; surgery
Mesh:
Year: 2016 PMID: 27059905 PMCID: PMC4827108 DOI: 10.1177/0141076816636369
Source DB: PubMed Journal: J R Soc Med ISSN: 0141-0768 Impact factor: 5.344